In adults with obesity but without type 2 diabetes, tirzepatide increased weight loss at 72 wk compared with semaglutide.
Where this comes from
- Record sourced from PubMed, PMID 41183340.
- Also identified by DOI 10.7326/ANNALS-25-04321-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Endocrinology: [Formula: see text].